Nephros, Inc.NEPHNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
26.61%
↑ 579% above average
Average (39q)
-5.56%
Historical baseline
Range
High:164.98%
Low:-252.58%
CAGR
+1.7%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 26.61% |
| Q2 2025 | -56.18% |
| Q1 2025 | 78.55% |
| Q4 2024 | 53.88% |
| Q3 2024 | 164.98% |
| Q2 2024 | -58.50% |
| Q1 2024 | 69.18% |
| Q4 2023 | -219.70% |
| Q3 2023 | 53.33% |
| Q2 2023 | -42.16% |
| Q1 2023 | 55.84% |
| Q4 2022 | 45.90% |
| Q3 2022 | -57.37% |
| Q2 2022 | 47.38% |
| Q1 2022 | -49.04% |
| Q4 2021 | -29.43% |
| Q3 2021 | 28.20% |
| Q2 2021 | -9.72% |
| Q1 2021 | -41.59% |
| Q4 2020 | 22.85% |
| Q3 2020 | 41.68% |
| Q2 2020 | -55.75% |
| Q1 2020 | -252.58% |
| Q4 2019 | 58.13% |
| Q3 2019 | 19.93% |
| Q2 2019 | 33.28% |
| Q1 2019 | -78.46% |
| Q4 2018 | -42.66% |
| Q3 2018 | 21.75% |
| Q2 2018 | 41.85% |
| Q1 2018 | -178.66% |
| Q4 2017 | 22.20% |
| Q3 2017 | 26.00% |
| Q2 2017 | -15.70% |
| Q1 2017 | 0.66% |
| Q4 2016 | 4.40% |
| Q3 2016 | 22.03% |
| Q2 2016 | -1.36% |
| Q1 2016 | 13.89% |
| Q4 2015 | 13.89% |